The Patent Finder

Hubit Genomix, Inc.

Also on record
Records under this name other than the patents Hubit Genomix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 3 of 3 · Back to Hubit Genomix, Inc.

PatentTitleStatus Expires Confidence
US 11,827,719Method for Primary Prevention of Allergic Disorders During Infancy Through IgE-Class-Specific Immunosuppression
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,901,874Methods for Identifying Agents for Preventing or Treating Proliferative Diseases, and for Inhibiting Extracellular Matrix or ALPHA1 Type IV Collagen
Term ended
Term ended Oct 10, 2026 · Medium confidence
Term endedTerm ended Oct 10, 2026Medium confidence
US 9,359,645Methods for detecting diabetic nephropathy comprising measuring the expression of Smad1
Lapsed on the fee record
Ended Jun 7, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 7, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited